- Clinical Studies of Risperidone in Korea
-
Kwon JS, Ha TH
- KMID: 1856375
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):128-139.
There have been 91 papers on risperidone in Korea, which were composed of 21 reviews, 9 preclinical studies, 18 case reports, and 43 clinical trials, since this new antipsychotic was... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Efficacy and Safety of Risperidone in Patients with Schizophrenia
-
Kim CY, Park CH
- KMID: 1856370
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):58-69.
Most informations on the efficacy and safety of new antipsychotic durgs are based on short-term clinical trials. Short-term studies are usually conducted as well-controlled, randomized, comparative studies. However, they do... -
- CITED
-
- Close
- SHARE
-
- Close
- Optimal Dosing and Recommended Dose-Schedule with Risperidone
-
Kim CH, Lee HS
- KMID: 1856369
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):46-57.
Although the establishment of appropriate dosage ranges and dose-up strategies for antipsychotic drugs has important ramifications for both short-term treatment and long-term therapeutic outcomes, difficulties in dosing persist. As a... -
- CITED
-
- Close
- SHARE
-
- Close
- Pre-Clinical Study of Risperidone
-
Chung IW
- KMID: 1856366
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):5-15.
Pre-clinical study has been carried out to explore the pharmacology, mechanism of actions, and toxicology of candidate materials for the new therapeutic drugs, and the additional biological mechanisms of drugs... -
- CITED
-
- Close
- SHARE
-
- Close
- Risperidone for Psychogeriatric Patients
-
Kim SH, Lee BH
- KMID: 1856373
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):101-111.
Elderly patients with dementia, delirium, schizophrenia and other psychotic symptoms are appropriate candidates for antipsychotic treatment. Risperidone is one of the newer atypical antipsychotic agents, which block serotonin and dopamine... -
- CITED
-
- Close
- SHARE
-
- Close
- The Clinical Use of Risperidone in Child & Adolescent Psychiatry
-
Kim BN
- KMID: 1856374
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):112-127.
The use of the antipsychotic drug, one of the most frequently prescribed drugs in child & adolescent psychiatry, has been limited because of the diverse serious side effects and questionable... -
- CITED
-
- Close
- SHARE
-
- Close
- The Effectiveness and Safety of Risperidone on Bipolar Disorders
-
Bahk WM, Lee KU
- KMID: 1856371
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):70-85.
Bipolar disorders affect about 1-2.5% of the population. They are leading causes of disability and associated with significant health care costs. Antipsychotic medicaitons have a long history of use in... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Trials of Risperidone in the Patients with Schizophrenia: Comparison with Other Antipsychotics
-
Kim YH
- KMID: 1856368
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):32-45.
Several double-blind comparative studies and two combined analysis of double-blind studies comparing the safety, tolerability and clinical efficacy of risperidone with those of haloperidol and other atypical antipsychotics were reviewed.... -
- CITED
-
- Close
- SHARE
-
- Close
- Risperidone Beyond Psychoses
-
Yoon DJ, Bahn GH
- KMID: 1856372
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):86-100.
The authors have compiled the available references on the use of risperidone in 'non-psychotic conditions', not including schizophrenia and bipolar disorders. In addition, information was gathered on the mechanism of... -
- CITED
-
- Close
- SHARE
-
- Close
- Risperidone: the Korean Experience in the Treatment of Patients with Schizophrenic Disorder
-
Yoon JS, Bae KL
- KMID: 1856367
- Korean J Psychopharmacol.
- 2003 Feb;14(Suppl):16-31.
Since the introduction in 1996 of the novel antipsychotic risperidone in Korea, clinical experiences with this agent for the treatment of schizophrenia have been accumulated. This article attempts to review... -
- CITED
-
- Close
- SHARE
-
- Close
